Better Therapeutics Inc. (BTTX)
0.00
null (null%)
At close: Jan 16, 2025, 3:00 PM
0.01
7300.00%
Pre-market Jun 20, 2024, 09:30 AM EDT
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -0.66 | -2.72 | -11.83 | -40.72 |
| PS Ratio | n/a | n/a | 9.45K | 13.11K |
| PB Ratio | -29.09 | 2.99 | -11.18 | -390.08 |
| P/FCF Ratio | -0.87 | -3.44 | -9.35 | -26.36 |
| P/OCF Ratio | -0.9 | -3.56 | -13.09 | -37.96 |
| OCF/S Ratio | n/a | n/a | -721.75 | -345.39 |
| Debt / Equity Ratio | -16.55 | 0.26 | -0.09 | -8.26 |
| Quick Ratio | 1.37 | 9.56 | 0.76 | 2.03 |
| Current Ratio | 1.37 | 9.56 | 0.76 | 2.03 |
| Asset Turnover | n/a | n/a | 0.00 | 0.00 |
| Interest Coverage | -25.66 | -165.19 | -63.23 | -524.82 |
| Return on Equity (ROE) | 44.23 | -1.1 | 0.95 | 9.58 |
| Return on Assets (ROA) | -1.73 | -0.79 | -1 | -1.19 |
| Return on Capital (ROIC) | -4.05 | -0.66 | -1.1 | -1.31 |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | -8.43K% | -4.89K% |
| Net Profit Margin | n/a | n/a | -79.84K% | -32.19K% |
| Pretax Profit Margin | n/a | n/a | -77.92K% | -32.13K% |
| Operating Profit Margin | n/a | n/a | -79.04K% | -32.07K% |
| FCF Margin | n/a | n/a | -100.99K% | -49.74K% |
| EBITDA Margin | n/a | n/a | -78.10K% | -31.67K% |